MANILA, Philippines — The clinical trials for Japan’s antiviral drug Avigan on coronavirus disease 2019 (COVID-19) patients in the Philippines have yet to start, the Department of Health (DOH) said Monday. “Ang Avigan trials natin hindi pa siya nag-uumpisa. Ana Hospital, Dr. Jose M. Rodriguez Memorial Hospital, and Quirino Memorial Medical Center will serve as sites for the clinical trials for Avigan which will run for nine months. The government has set aside at least P18 million for the Avigan trials. Vergeire said there are currently 932 patients enrolled in WHO’s solidarity trials in the country.

Source: Philippine Daily Inquirer August 24, 2020 03:56 UTC